# GO_biological_process_0129: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_biological_process_0129.txt)

**Task:** `GO_biological_process`  
**Author key, unchanged:** **B** — lipopolysaccharide core region biosynthetic process

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | contradicted | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | contradicted | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MTSHHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVAVMGAMLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMNLAFFVRIIGLGVLPSVLVAVAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVFVVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPATQYFDYKSATNNTICNTNPYNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTAGKVKDRAAFIQ

[Multiple Choices]
A. carotenoid biosynthetic process
B. lipopolysaccharide core region biosynthetic process
C. meiotic DNA integrity checkpoint signaling
D. cell adhesion
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: contradicted

> The sequence matches MCR-2, whose reported activity is adding phosphoethanolamine to lipid A. That is distinct from synthesizing the LPS core region. The B annotation exists, but it is computationally assigned (IEA:TreeGrafter) and does not outweigh the more specific functional evidence for the different process.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [GO2](#evidence-go2), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has multiple hydrophobic segments and a large enzymatic region, but those features do not identify its substrate or distinguish the listed biosynthetic pathways with confidence.


**Missing item-specific fact**

> The protein-specific activity—that MCR-2 modifies lipid A by transferring phosphoethanolamine—and its database GO annotation are not supplied in the question.


**Reason**

> Choosing among these processes requires knowing the particular protein's function or annotation; exact-sequence recognition or a generic membrane-protein heuristic would not provide a biological argument for the specific GO term.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The choices do not include lipid A modification, the reported activity. B is the only LPS-related option, but its specific reference to core-region biosynthesis does not describe that activity.


### Important caveats

- The B GO assignment applies to the sequence but is computationally inferred, not presented as experimental evidence.
- The reported functional annotation says MCR-2 probably catalyzes lipid A modification; it does not establish that the protein has no other biological effects.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has multiple hydrophobic segments and a large enzymatic region, but those features do not identify its substrate or distinguish the listed biosynthetic pathways with confidence.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific activity—that MCR-2 modifies lipid A by transferring phosphoethanolamine—and its database GO annotation are not supplied in the question.",
    "reason": "Choosing among these processes requires knowing the particular protein's function or annotation; exact-sequence recognition or a generic membrane-protein heuristic would not provide a biological argument for the specific GO term."
  },
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "GO2",
      "H3",
      "H4"
    ],
    "judgment": "contradicted",
    "reason": "The sequence matches MCR-2, whose reported activity is adding phosphoethanolamine to lipid A. That is distinct from synthesizing the LPS core region. The B annotation exists, but it is computationally assigned (IEA:TreeGrafter) and does not outweigh the more specific functional evidence for the different process."
  },
  "important_caveats": [
    "The B GO assignment applies to the sequence but is computationally inferred, not presented as experimental evidence.",
    "The reported functional annotation says MCR-2 probably catalyzes lipid A modification; it does not establish that the protein has no other biological effects."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices do not include lipid A modification, the reported activity. B is the only LPS-related option, but its specific reference to core-region biosynthesis does not describe that activity."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "judgment": "contradicted",
    "reason": "The sequence matches MCR-2, whose reported activity is adding phosphoethanolamine to lipid A. That is distinct from synthesizing the LPS core region. The B annotation exists, but it is computationally assigned (IEA:TreeGrafter) and does not outweigh the more specific functional evidence for the different process.",
    "evidence_ids": ["C4", "C5", "C6", "GO2", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has multiple hydrophobic segments and a large enzymatic region, but those features do not identify its substrate or distinguish the listed biosynthetic pathways with confidence.",
    "missing_item_specific_fact": "The protein-specific activity—that MCR-2 modifies lipid A by transferring phosphoethanolamine—and its database GO annotation are not supplied in the question.",
    "reason": "Choosing among these processes requires knowing the particular protein's function or annotation; exact-sequence recognition or a generic membrane-protein heuristic would not provide a biological argument for the specific GO term."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices do not include lipid A modification, the reported activity. B is the only LPS-related option, but its specific reference to core-region biosynthesis does not describe that activity."
  },
  "important_caveats": [
    "The B GO assignment applies to the sequence but is computationally inferred, not presented as experimental evidence.",
    "The reported functional annotation says MCR-2 probably catalyzes lipid A modification; it does not establish that the protein has no other biological effects."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A1C3NEV1 (MCR-2, Phosphatidylethanolamine transferase) carries GO:0009244 (lipopolysaccharide core region biosynthetic process) as an annotation (C6, H4). The protein's experimentally characterized function (PubMed:30194678, PDB:6A7W) is phosphoethanolamine transfer to lipid A, which is part of LPS modification. However, the GO annotation is IEA:TreeGrafter (automated/computational), and the term 'core region biosynthetic process' specifically refers to the ten-saccharide oligosaccharide core (GO2), whereas MCR-2 modifies lipid A rather than the core region. The annotation is present in the database and matches the expected answer, but it is an approximate automated assignment rather than a precise functional description.

Citations as saved: [C6](#evidence-c6), [H4](#evidence-h4), [C5](#evidence-c5), [H3](#evidence-h3), [GO2](#evidence-go2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence encodes a ~538-residue protein with multiple N-terminal transmembrane helices and a cytoplasmic/periplasmic catalytic domain, consistent with a membrane-associated transferase from a Gram-negative bacterium (E. coli). Among the four options: (C) meiotic DNA integrity checkpoint signaling is exclusively eukaryotic and irrelevant to a bacterial protein; (D) cell adhesion does not match a membrane transferase; (A) carotenoid biosynthetic process involves tetraterpenoid pathway enzymes with entirely different domain architecture. Option (B) is the only LPS/lipid-metabolism-related process, and recognizing the protein as a lipid-modifying membrane enzyme in E. coli (a LPS-containing organism) provides a defensible biological argument for selecting B over the clearly inappropriate distractors.


**Missing item-specific fact**

> Precise identification of the protein as a phosphatidylethanolamine transferase modifying lipid A (rather than, say, a general lipid kinase or acyltransferase) requires either domain-level recognition of the PptA/MCR fold or database lookup. The specific sub-process 'core region biosynthetic process' (as opposed to 'lipid A biosynthetic process') is an imprecise automated annotation assignment not derivable from sequence reasoning alone.


**Reason**

> While the exact GO term 'lipopolysaccharide core region biosynthetic process' is an automated (IEA:TreeGrafter) annotation that slightly mischaracterizes the lipid A modification function, the question's four options are sufficiently distinct that general biological reasoning—bacterial origin, membrane topology, transferase architecture, and elimination of eukaryotic-only or unrelated processes—can meaningfully narrow the answer to B without memorizing this specific protein's database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The three distractors (carotenoid biosynthesis, meiotic checkpoint signaling, cell adhesion) are clearly incompatible with a bacterial membrane transferase. No other option is defensible for this protein.


### Important caveats

- The GO:0009244 annotation is IEA:TreeGrafter (automated), not experimentally derived. The protein's experimentally validated function is phosphoethanolamine transfer to lipid A (EC 2.7.8.43), which is more precisely 'lipid A modification' than 'core region biosynthetic process.'
- The GO term definition specifies the ten-saccharide core oligosaccharide, which is distinct from lipid A. The automated annotation appears to place lipid A modification under the broader LPS biosynthesis umbrella via TreeGrafter inference.
- The protein is a plasmid-encoded polymyxin/colistin resistance factor (MCR-2), not a constitutive LPS biosynthetic enzyme, which adds contextual nuance to the 'biosynthetic process' framing.
- All reviewer evidence is from UniProt entry A0A1C3NEV1, which was first publicly released 2025-06-18; the benchmark author's source snapshot is unknown but sequence matches confirmed.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence encodes a ~538-residue protein with multiple N-terminal transmembrane helices and a cytoplasmic/periplasmic catalytic domain, consistent with a membrane-associated transferase from a Gram-negative bacterium (E. coli). Among the four options: (C) meiotic DNA integrity checkpoint signaling is exclusively eukaryotic and irrelevant to a bacterial protein; (D) cell adhesion does not match a membrane transferase; (A) carotenoid biosynthetic process involves tetraterpenoid pathway enzymes with entirely different domain architecture. Option (B) is the only LPS/lipid-metabolism-related process, and recognizing the protein as a lipid-modifying membrane enzyme in E. coli (a LPS-containing organism) provides a defensible biological argument for selecting B over the clearly inappropriate distractors.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Precise identification of the protein as a phosphatidylethanolamine transferase modifying lipid A (rather than, say, a general lipid kinase or acyltransferase) requires either domain-level recognition of the PptA/MCR fold or database lookup. The specific sub-process 'core region biosynthetic process' (as opposed to 'lipid A biosynthetic process') is an imprecise automated annotation assignment not derivable from sequence reasoning alone.",
    "reason": "While the exact GO term 'lipopolysaccharide core region biosynthetic process' is an automated (IEA:TreeGrafter) annotation that slightly mischaracterizes the lipid A modification function, the question's four options are sufficiently distinct that general biological reasoning—bacterial origin, membrane topology, transferase architecture, and elimination of eukaryotic-only or unrelated processes—can meaningfully narrow the answer to B without memorizing this specific protein's database entry."
  },
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H4",
      "C5",
      "H3",
      "GO2"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A1C3NEV1 (MCR-2, Phosphatidylethanolamine transferase) carries GO:0009244 (lipopolysaccharide core region biosynthetic process) as an annotation (C6, H4). The protein's experimentally characterized function (PubMed:30194678, PDB:6A7W) is phosphoethanolamine transfer to lipid A, which is part of LPS modification. However, the GO annotation is IEA:TreeGrafter (automated/computational), and the term 'core region biosynthetic process' specifically refers to the ten-saccharide oligosaccharide core (GO2), whereas MCR-2 modifies lipid A rather than the core region. The annotation is present in the database and matches the expected answer, but it is an approximate automated assignment rather than a precise functional description."
  },
  "important_caveats": [
    "The GO:0009244 annotation is IEA:TreeGrafter (automated), not experimentally derived. The protein's experimentally validated function is phosphoethanolamine transfer to lipid A (EC 2.7.8.43), which is more precisely 'lipid A modification' than 'core region biosynthetic process.'",
    "The GO term definition specifies the ten-saccharide core oligosaccharide, which is distinct from lipid A. The automated annotation appears to place lipid A modification under the broader LPS biosynthesis umbrella via TreeGrafter inference.",
    "The protein is a plasmid-encoded polymyxin/colistin resistance factor (MCR-2), not a constitutive LPS biosynthetic enzyme, which adds contextual nuance to the 'biosynthetic process' framing.",
    "All reviewer evidence is from UniProt entry A0A1C3NEV1, which was first publicly released 2025-06-18; the benchmark author's source snapshot is unknown but sequence matches confirmed."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (carotenoid biosynthesis, meiotic checkpoint signaling, cell adhesion) are clearly incompatible with a bacterial membrane transferase. No other option is defensible for this protein."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A1C3NEV1 (MCR-2, Phosphatidylethanolamine transferase) carries GO:0009244 (lipopolysaccharide core region biosynthetic process) as an annotation (C6, H4). The protein's experimentally characterized function (PubMed:30194678, PDB:6A7W) is phosphoethanolamine transfer to lipid A, which is part of LPS modification. However, the GO annotation is IEA:TreeGrafter (automated/computational), and the term 'core region biosynthetic process' specifically refers to the ten-saccharide oligosaccharide core (GO2), whereas MCR-2 modifies lipid A rather than the core region. The annotation is present in the database and matches the expected answer, but it is an approximate automated assignment rather than a precise functional description.",
    "evidence_ids": ["C6", "H4", "C5", "H3", "GO2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence encodes a ~538-residue protein with multiple N-terminal transmembrane helices and a cytoplasmic/periplasmic catalytic domain, consistent with a membrane-associated transferase from a Gram-negative bacterium (E. coli). Among the four options: (C) meiotic DNA integrity checkpoint signaling is exclusively eukaryotic and irrelevant to a bacterial protein; (D) cell adhesion does not match a membrane transferase; (A) carotenoid biosynthetic process involves tetraterpenoid pathway enzymes with entirely different domain architecture. Option (B) is the only LPS/lipid-metabolism-related process, and recognizing the protein as a lipid-modifying membrane enzyme in E. coli (a LPS-containing organism) provides a defensible biological argument for selecting B over the clearly inappropriate distractors.",
    "missing_item_specific_fact": "Precise identification of the protein as a phosphatidylethanolamine transferase modifying lipid A (rather than, say, a general lipid kinase or acyltransferase) requires either domain-level recognition of the PptA/MCR fold or database lookup. The specific sub-process 'core region biosynthetic process' (as opposed to 'lipid A biosynthetic process') is an imprecise automated annotation assignment not derivable from sequence reasoning alone.",
    "reason": "While the exact GO term 'lipopolysaccharide core region biosynthetic process' is an automated (IEA:TreeGrafter) annotation that slightly mischaracterizes the lipid A modification function, the question's four options are sufficiently distinct that general biological reasoning—bacterial origin, membrane topology, transferase architecture, and elimination of eukaryotic-only or unrelated processes—can meaningfully narrow the answer to B without memorizing this specific protein's database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (carotenoid biosynthesis, meiotic checkpoint signaling, cell adhesion) are clearly incompatible with a bacterial membrane transferase. No other option is defensible for this protein."
  },
  "important_caveats": [
    "The GO:0009244 annotation is IEA:TreeGrafter (automated), not experimentally derived. The protein's experimentally validated function is phosphoethanolamine transfer to lipid A (EC 2.7.8.43), which is more precisely 'lipid A modification' than 'core region biosynthetic process.'",
    "The GO term definition specifies the ten-saccharide core oligosaccharide, which is distinct from lipid A. The automated annotation appears to place lipid A modification under the broader LPS biosynthesis umbrella via TreeGrafter inference.",
    "The protein is a plasmid-encoded polymyxin/colistin resistance factor (MCR-2), not a constitutive LPS biosynthetic enzyme, which adds contextual nuance to the 'biosynthetic process' framing.",
    "All reviewer evidence is from UniProt entry A0A1C3NEV1, which was first publicly released 2025-06-18; the benchmark author's source snapshot is unknown but sequence matches confirmed."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: contradicted

> The matched-sequence annotation assigns B computationally (IEA:TreeGrafter), but the protein is described as a phosphatidylethanolamine transferase that adds a phosphoethanolamine moiety to lipid A. The supplied GO definition for B concerns formation of the LPS core's saccharide region, a distinct process; the annotation alone does not establish that function.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [GO2](#evidence-go2), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence's N-terminal multipass membrane region and large C-terminal catalytic region are consistent with the transferable family pattern of bacterial membrane-associated lipid A-modifying phosphoethanolamine transferases. That points to LPS-related biology and meaningfully favors B over carotenoid biosynthesis, meiotic checkpoint signaling, or cell adhesion. However, the inference supports lipid A modification, not specifically biosynthesis of the LPS core saccharides.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A family-level inference from the sequence and general knowledge of bacterial envelope enzymes distinguishes the nearest offered choice without requiring the exact protein's database record. The choice is only an approximate match to the inferred function, so this does not validate the key's specific process annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> No second option is comparably supported by the sequence. B is the only LPS-related choice, although its specific core-region process does not match the indicated lipid A modification.


### Important caveats

- The supplied GO assignment is computational (IEA:TreeGrafter), whereas the function evidence describes lipid A modification; the evidence does not establish that B is correct.
- The source sequence matches the supplied sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence's N-terminal multipass membrane region and large C-terminal catalytic region are consistent with the transferable family pattern of bacterial membrane-associated lipid A-modifying phosphoethanolamine transferases. That points to LPS-related biology and meaningfully favors B over carotenoid biosynthesis, meiotic checkpoint signaling, or cell adhesion. However, the inference supports lipid A modification, not specifically biosynthesis of the LPS core saccharides.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A family-level inference from the sequence and general knowledge of bacterial envelope enzymes distinguishes the nearest offered choice without requiring the exact protein's database record. The choice is only an approximate match to the inferred function, so this does not validate the key's specific process annotation."
  },
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "GO2",
      "H3",
      "H4"
    ],
    "judgment": "contradicted",
    "reason": "The matched-sequence annotation assigns B computationally (IEA:TreeGrafter), but the protein is described as a phosphatidylethanolamine transferase that adds a phosphoethanolamine moiety to lipid A. The supplied GO definition for B concerns formation of the LPS core's saccharide region, a distinct process; the annotation alone does not establish that function."
  },
  "important_caveats": [
    "The supplied GO assignment is computational (IEA:TreeGrafter), whereas the function evidence describes lipid A modification; the evidence does not establish that B is correct.",
    "The source sequence matches the supplied sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No second option is comparably supported by the sequence. B is the only LPS-related choice, although its specific core-region process does not match the indicated lipid A modification."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "judgment": "contradicted",
    "reason": "The matched-sequence annotation assigns B computationally (IEA:TreeGrafter), but the protein is described as a phosphatidylethanolamine transferase that adds a phosphoethanolamine moiety to lipid A. The supplied GO definition for B concerns formation of the LPS core's saccharide region, a distinct process; the annotation alone does not establish that function.",
    "evidence_ids": ["C5", "C6", "GO2", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence's N-terminal multipass membrane region and large C-terminal catalytic region are consistent with the transferable family pattern of bacterial membrane-associated lipid A-modifying phosphoethanolamine transferases. That points to LPS-related biology and meaningfully favors B over carotenoid biosynthesis, meiotic checkpoint signaling, or cell adhesion. However, the inference supports lipid A modification, not specifically biosynthesis of the LPS core saccharides.",
    "missing_item_specific_fact": "",
    "reason": "A family-level inference from the sequence and general knowledge of bacterial envelope enzymes distinguishes the nearest offered choice without requiring the exact protein's database record. The choice is only an approximate match to the inferred function, so this does not validate the key's specific process annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No second option is comparably supported by the sequence. B is the only LPS-related choice, although its specific core-region process does not match the indicated lipid A modification."
  },
  "important_caveats": [
    "The supplied GO assignment is computational (IEA:TreeGrafter), whereas the function evidence describes lipid A modification; the evidence does not establish that B is correct.",
    "The source sequence matches the supplied sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A1C3NEV1 (MCR-2, Phosphatidylethanolamine transferase) carries the GO annotation GO:0009244 (lipopolysaccharide core region biosynthetic process) as option B. However, this annotation is IEA:TreeGrafter (purely computational phylogenetic inference), not experimental. The actual experimental evidence (PubMed:30194678, PDB:6A7W) demonstrates the protein catalyzes addition of phosphoethanolamine to lipid A, which is the lipid moiety of LPS, not the core oligosaccharide region. The GO term definition explicitly states 'formation of the core region of bacterial lipopolysaccharides, which contains ten saccharide residues.' The annotation is thus a computational inference that is broadly related to LPS modification but imprecise for this specific protein. The annotation does exist in the database, so the key is technically supported by the supplied evidence, albeit via a low-confidence evidence code.

Citations as saved: [C6](#evidence-c6), [H4](#evidence-h4), [C5](#evidence-c5), [H3](#evidence-h3), [GO2](#evidence-go2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> A knowledgeable model can reason to B through several converging lines of transferable knowledge: (1) The sequence composition and architecture indicate a bacterial inner-membrane protein with ~5-6 N-terminal transmembrane helices followed by a large cytoplasmic catalytic domain (~250+ residues), which is the hallmark architecture of the MCR/phosphatidylethanolamine transferase family. (2) MCR-family proteins (MCR-1, MCR-2, MCR-3, etc.) are well-characterized as LPS/lipid A modifying enzymes that confer polymyxin/colistin resistance — this is a family-level inference from multiple characterized homologs. (3) Option C (meiotic DNA integrity checkpoint signaling) is a eukaryotic-specific process involving proteins like ATR/CHK2, immediately eliminated by the bacterial sequence context. (4) Option A (carotenoid biosynthesis) involves enzymes with distinct domains (phytoene synthase, lycopene cyclase, carotenoid hydroxylase) with different membrane topology — not matching this architecture. (5) Option D (cell adhesion) involves surface-exposed binding domains (integrins, cadherins, bacterial adhesins with Ig-like or FN3 domains), inconsistent with the multi-TM + cytoplasmic catalytic fold seen here. (6) Among the four options, only B relates to LPS modification, making it the clear best fit for an enzyme that modifies LPS components, even if the precise GO term 'core region' is slightly imprecise for lipid A modification.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The protein's multi-TM inner membrane architecture with a large cytoplasmic catalytic domain is a recognizable family signature (MCR/phosphatidylethanolamine transferases) shared across multiple characterized homologs. Family-level knowledge that these enzymes modify LPS/lipid A, combined with elimination of clearly incompatible options (eukaryotic checkpoint, carotenoid pathway, adhesion), provides a concrete and defensible path to option B without requiring recall of this exact protein's database record.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Although the GO term GO:0009244 ('core region biosynthetic process') is technically imprecise for a lipid A-modifying enzyme, among the four offered options only B relates to LPS modification at all. Options A, C, and D are clearly incompatible with the protein's bacterial origin, membrane architecture, and enzymatic function. No alternative option is defensible.


### Important caveats

- The GO annotation supporting option B is IEA:TreeGrafter (computational phylogenetic inference), not experimental evidence. The experimental data (PubMed:30194678, PDB:6A7W) support lipid A modification, not core region biosynthesis.
- The GO term GO:0009244 specifically refers to the 10-saccharide core region of LPS, while MCR-2 adds phosphoethanolamine to lipid A. A more precise term would be 'lipid A biosynthetic process' or the parent 'lipopolysaccharide biosynthetic process' (GO:0009103).
- The sequence was identified as MCR-2 from E. coli (plasmid-encoded), but organism identity and protein name were not provided to the evaluated model; the reasoning must rely on sequence features and family knowledge.
- The entry was first public in June 2025 and the benchmark cutoff is 2026-05-07; the Swiss-Prot reviewed status (entry version 38, released Jan 2026) was available at cutoff.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A knowledgeable model can reason to B through several converging lines of transferable knowledge: (1) The sequence composition and architecture indicate a bacterial inner-membrane protein with ~5-6 N-terminal transmembrane helices followed by a large cytoplasmic catalytic domain (~250+ residues), which is the hallmark architecture of the MCR/phosphatidylethanolamine transferase family. (2) MCR-family proteins (MCR-1, MCR-2, MCR-3, etc.) are well-characterized as LPS/lipid A modifying enzymes that confer polymyxin/colistin resistance — this is a family-level inference from multiple characterized homologs. (3) Option C (meiotic DNA integrity checkpoint signaling) is a eukaryotic-specific process involving proteins like ATR/CHK2, immediately eliminated by the bacterial sequence context. (4) Option A (carotenoid biosynthesis) involves enzymes with distinct domains (phytoene synthase, lycopene cyclase, carotenoid hydroxylase) with different membrane topology — not matching this architecture. (5) Option D (cell adhesion) involves surface-exposed binding domains (integrins, cadherins, bacterial adhesins with Ig-like or FN3 domains), inconsistent with the multi-TM + cytoplasmic catalytic fold seen here. (6) Among the four options, only B relates to LPS modification, making it the clear best fit for an enzyme that modifies LPS components, even if the precise GO term 'core region' is slightly imprecise for lipid A modification.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The protein's multi-TM inner membrane architecture with a large cytoplasmic catalytic domain is a recognizable family signature (MCR/phosphatidylethanolamine transferases) shared across multiple characterized homologs. Family-level knowledge that these enzymes modify LPS/lipid A, combined with elimination of clearly incompatible options (eukaryotic checkpoint, carotenoid pathway, adhesion), provides a concrete and defensible path to option B without requiring recall of this exact protein's database record."
  },
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H4",
      "C5",
      "H3",
      "GO2"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A1C3NEV1 (MCR-2, Phosphatidylethanolamine transferase) carries the GO annotation GO:0009244 (lipopolysaccharide core region biosynthetic process) as option B. However, this annotation is IEA:TreeGrafter (purely computational phylogenetic inference), not experimental. The actual experimental evidence (PubMed:30194678, PDB:6A7W) demonstrates the protein catalyzes addition of phosphoethanolamine to lipid A, which is the lipid moiety of LPS, not the core oligosaccharide region. The GO term definition explicitly states 'formation of the core region of bacterial lipopolysaccharides, which contains ten saccharide residues.' The annotation is thus a computational inference that is broadly related to LPS modification but imprecise for this specific protein. The annotation does exist in the database, so the key is technically supported by the supplied evidence, albeit via a low-confidence evidence code."
  },
  "important_caveats": [
    "The GO annotation supporting option B is IEA:TreeGrafter (computational phylogenetic inference), not experimental evidence. The experimental data (PubMed:30194678, PDB:6A7W) support lipid A modification, not core region biosynthesis.",
    "The GO term GO:0009244 specifically refers to the 10-saccharide core region of LPS, while MCR-2 adds phosphoethanolamine to lipid A. A more precise term would be 'lipid A biosynthetic process' or the parent 'lipopolysaccharide biosynthetic process' (GO:0009103).",
    "The sequence was identified as MCR-2 from E. coli (plasmid-encoded), but organism identity and protein name were not provided to the evaluated model; the reasoning must rely on sequence features and family knowledge.",
    "The entry was first public in June 2025 and the benchmark cutoff is 2026-05-07; the Swiss-Prot reviewed status (entry version 38, released Jan 2026) was available at cutoff."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although the GO term GO:0009244 ('core region biosynthetic process') is technically imprecise for a lipid A-modifying enzyme, among the four offered options only B relates to LPS modification at all. Options A, C, and D are clearly incompatible with the protein's bacterial origin, membrane architecture, and enzymatic function. No alternative option is defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0129",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A1C3NEV1 (MCR-2, Phosphatidylethanolamine transferase) carries the GO annotation GO:0009244 (lipopolysaccharide core region biosynthetic process) as option B. However, this annotation is IEA:TreeGrafter (purely computational phylogenetic inference), not experimental. The actual experimental evidence (PubMed:30194678, PDB:6A7W) demonstrates the protein catalyzes addition of phosphoethanolamine to lipid A, which is the lipid moiety of LPS, not the core oligosaccharide region. The GO term definition explicitly states 'formation of the core region of bacterial lipopolysaccharides, which contains ten saccharide residues.' The annotation is thus a computational inference that is broadly related to LPS modification but imprecise for this specific protein. The annotation does exist in the database, so the key is technically supported by the supplied evidence, albeit via a low-confidence evidence code.",
    "evidence_ids": ["C6", "H4", "C5", "H3", "GO2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "A knowledgeable model can reason to B through several converging lines of transferable knowledge: (1) The sequence composition and architecture indicate a bacterial inner-membrane protein with ~5-6 N-terminal transmembrane helices followed by a large cytoplasmic catalytic domain (~250+ residues), which is the hallmark architecture of the MCR/phosphatidylethanolamine transferase family. (2) MCR-family proteins (MCR-1, MCR-2, MCR-3, etc.) are well-characterized as LPS/lipid A modifying enzymes that confer polymyxin/colistin resistance — this is a family-level inference from multiple characterized homologs. (3) Option C (meiotic DNA integrity checkpoint signaling) is a eukaryotic-specific process involving proteins like ATR/CHK2, immediately eliminated by the bacterial sequence context. (4) Option A (carotenoid biosynthesis) involves enzymes with distinct domains (phytoene synthase, lycopene cyclase, carotenoid hydroxylase) with different membrane topology — not matching this architecture. (5) Option D (cell adhesion) involves surface-exposed binding domains (integrins, cadherins, bacterial adhesins with Ig-like or FN3 domains), inconsistent with the multi-TM + cytoplasmic catalytic fold seen here. (6) Among the four options, only B relates to LPS modification, making it the clear best fit for an enzyme that modifies LPS components, even if the precise GO term 'core region' is slightly imprecise for lipid A modification.",
    "missing_item_specific_fact": "",
    "reason": "The protein's multi-TM inner membrane architecture with a large cytoplasmic catalytic domain is a recognizable family signature (MCR/phosphatidylethanolamine transferases) shared across multiple characterized homologs. Family-level knowledge that these enzymes modify LPS/lipid A, combined with elimination of clearly incompatible options (eukaryotic checkpoint, carotenoid pathway, adhesion), provides a concrete and defensible path to option B without requiring recall of this exact protein's database record."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although the GO term GO:0009244 ('core region biosynthetic process') is technically imprecise for a lipid A-modifying enzyme, among the four offered options only B relates to LPS modification at all. Options A, C, and D are clearly incompatible with the protein's bacterial origin, membrane architecture, and enzymatic function. No alternative option is defensible."
  },
  "important_caveats": [
    "The GO annotation supporting option B is IEA:TreeGrafter (computational phylogenetic inference), not experimental evidence. The experimental data (PubMed:30194678, PDB:6A7W) support lipid A modification, not core region biosynthesis.",
    "The GO term GO:0009244 specifically refers to the 10-saccharide core region of LPS, while MCR-2 adds phosphoethanolamine to lipid A. A more precise term would be 'lipid A biosynthetic process' or the parent 'lipopolysaccharide biosynthetic process' (GO:0009103).",
    "The sequence was identified as MCR-2 from E. coli (plasmid-encoded), but organism identity and protein name were not provided to the evaluated model; the reasoning must rely on sequence features and family knowledge.",
    "The entry was first public in June 2025 and the benchmark cutoff is 2026-05-07; the Swiss-Prot reviewed status (entry version 38, released Jan 2026) was available at cutoff."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

### Source check 1

**Check:** `mixed_annotations_require_qualification`.

> C5/H3 say probably lipid-A phosphoethanolamine addition, while C6/H4 explicitly carry the keyed LPS-core biosynthesis term with IEA:TreeGrafter. GO2 defines core-region synthesis.

**Remaining uncertainty:** Retain both annotations and the word probably; neither the existence nor the lower evidence class of a GO label alone resolves biological validity or exclusivity.

Evidence checked: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [GO2](#evidence-go2), [H3](#evidence-h3), [H4](#evidence-h4).

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A1C3NEV1",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "ac11cd8f4c43b75871bc89c0dbaa1f186110d0c878b6152a899c2abf8270e1ac",
  "benchmark_sequence_length": 538,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 40,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2016-11-02",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "current_source_sequence_sha256": "ac11cd8f4c43b75871bc89c0dbaa1f186110d0c878b6152a899c2abf8270e1ac",
  "current_source_sequence_length": 538,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 38,
  "selected_historical_version": {
    "accession": "A0A1C3NEV1",
    "database": "Swiss-Prot",
    "entryVersion": 38,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "MCR2_ECOLX",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "d75fc4c8bc738f05806f3af9945e4dc68a9d390599953db777a2ada2b9fa9923",
  "selected_historical_source_sequence_sha256": "ac11cd8f4c43b75871bc89c0dbaa1f186110d0c878b6152a899c2abf8270e1ac",
  "selected_historical_source_sequence_length": 538,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 38,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json",
  "source_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "retrieved_utc": "2026-11-02T04:24:32.663314+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A1C3NEV1\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json",
  "source_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "retrieved_utc": "2026-11-02T04:24:32.663314+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":40,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2016-11-02\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json",
  "source_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "retrieved_utc": "2026-11-02T04:24:32.663314+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"SBV31106.1\",\"source\":\"EMBL\"}],\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Pseudomonadota\",\"Gammaproteobacteria\",\"Enterobacterales\",\"Enterobacteriaceae\",\"Escherichia\"],\"scientificName\":\"Escherichia coli\",\"taxonId\":562}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json",
  "source_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "retrieved_utc": "2026-11-02T04:24:32.663314+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"A0A0R6L508\",\"source\":\"UniProtKB\"}],\"value\":\"Polymyxin resistance protein MCR-2\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"30194678\",\"source\":\"PubMed\"}],\"value\":\"2.7.8.43\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"30194678\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000303\",\"id\":\"Ref.1\",\"source\":\"Reference\"}],\"value\":\"Phosphatidylethanolamine transferase Mcr-2\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json",
  "source_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "retrieved_utc": "2026-11-02T04:24:32.663314+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"A0A0R6L508\",\"source\":\"UniProtKB\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"30194678\",\"source\":\"PubMed\"}],\"value\":\"Probably catalyzes the addition of a phosphoethanolamine moiety to lipid A (PubMed:30194678). Phosphoethanolamine modification of lipid A confers polymyxin resistance (By similarity). Confers resistance to polymyxin-type antibiotics such as colistin (PubMed:30194678)\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json",
  "source_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "retrieved_utc": "2026-11-02T04:24:32.663314+00:00",
  "json_pointer": "/uniProtKBCrossReferences/16",
  "excerpt": "{\"database\":\"GO\",\"id\":\"GO:0009244\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"P:lipopolysaccharide core region biosynthetic process\"},{\"key\":\"GoEvidenceType\",\"value\":\"IEA:TreeGrafter\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1C3NEV1.json",
  "source_sha256": "919af10a00ec31395e30970b3152dc7099658836191b0b0da093f5ea34918d31",
  "retrieved_utc": "2026-11-02T04:24:32.663314+00:00",
  "json_pointer": "/references/3",
  "excerpt": "{\"citation\":{\"authors\":[\"Wang X.\",\"Lu Q.\",\"Qi J.\",\"Chai Y.\",\"Wang Y.\",\"Gao G.F.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"30194678\"},{\"database\":\"DOI\",\"id\":\"10.1007/s11427-018-9363-4\"}],\"citationType\":\"journal article\",\"firstPage\":\"1432\",\"id\":\"30194678\",\"journal\":\"Sci. China Life Sci.\",\"lastPage\":\"1436\",\"publicationDate\":\"2018\",\"title\":\"Structural and functional insights into MCR-2 mediated colistin resistance.\",\"volume\":\"61\"},\"evidences\":[{\"evidenceCode\":\"ECO:0007744\",\"id\":\"6A7W\",\"source\":\"PDB\"}],\"referenceComments\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"WHI04997.1\",\"source\":\"EMBL\"}],\"type\":\"PLASMID\",\"value\":\"unnamed5\"}],\"referenceNumber\":4,\"referencePositions\":[\"X-RAY CRYSTALLOGRAPHY (2.99 ANGSTROMS) OF 215-538 IN COMPLEX WITH ZN(2+)\",\"DISULFIDE BONDS\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"MUTAGENESIS OF PHE-91; TYR-99; MET-103; ASN-106; THR-110; GLU-114; SER-115; PHE-123; THR-283; LYS-331 AND HIS-476\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38",
  "source_sha256": "d75fc4c8bc738f05806f3af9945e4dc68a9d390599953db777a2ada2b9fa9923",
  "retrieved_utc": "2026-11-02T04:24:35.172422+00:00",
  "source_locator": "lines 1-16",
  "excerpt": "ID   MCR2_ECOLX              Reviewed;         538 AA.\nAC   A0A1C3NEV1;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   02-NOV-2016, sequence version 1.\nDT   28-JAN-2026, entry version 38.\nDE   RecName: Full=Phosphatidylethanolamine transferase Mcr-2 {ECO:0000303|PubMed:30194678, ECO:0000303|Ref.1};\nDE            EC=2.7.8.43 {ECO:0000305|PubMed:30194678};\nDE   AltName: Full=Polymyxin resistance protein MCR-2 {ECO:0000250|UniProtKB:A0A0R6L508};\nGN   Name=mcr2 {ECO:0000305}; Synonyms=mcr-2 {ECO:0000312|EMBL:SBV31106.1};\nGN   ORFNames=QDW62_28200 {ECO:0000312|EMBL:WHI04997.1};\nOS   Escherichia coli.\nOG   Plasmid pKP37-BE {ECO:0000312|EMBL:SBV31106.1}, and\nOG   Plasmid unnamed5 {ECO:0000312|EMBL:WHI04997.1}.\nOC   Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria;\nOC   Enterobacterales; Enterobacteriaceae; Escherichia.\nOX   NCBI_TaxID=562 {ECO:0000312|EMBL:SBV31106.1};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 38,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38",
  "source_sha256": "d75fc4c8bc738f05806f3af9945e4dc68a9d390599953db777a2ada2b9fa9923",
  "retrieved_utc": "2026-11-02T04:24:35.172422+00:00",
  "source_locator": "lines 44-54",
  "excerpt": "RN   [4] {ECO:0007744|PDB:6A7W}\nRP   X-RAY CRYSTALLOGRAPHY (2.99 ANGSTROMS) OF 215-538 IN COMPLEX WITH ZN(2+),\nRP   DISULFIDE BONDS, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF PHE-91;\nRP   TYR-99; MET-103; ASN-106; THR-110; GLU-114; SER-115; PHE-123; THR-283;\nRP   LYS-331 AND HIS-476.\nRC   PLASMID=unnamed5 {ECO:0000312|EMBL:WHI04997.1};\nRX   PubMed=30194678; DOI=10.1007/s11427-018-9363-4;\nRA   Wang X., Lu Q., Qi J., Chai Y., Wang Y., Gao G.F.;\nRT   \"Structural and functional insights into MCR-2 mediated colistin\nRT   resistance.\";\nRL   Sci. China Life Sci. 61:1432-1436(2018).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 38,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38",
  "source_sha256": "d75fc4c8bc738f05806f3af9945e4dc68a9d390599953db777a2ada2b9fa9923",
  "retrieved_utc": "2026-11-02T04:24:35.172422+00:00",
  "source_locator": "lines 66-71",
  "excerpt": "CC   -!- FUNCTION: Probably catalyzes the addition of a phosphoethanolamine\nCC       moiety to lipid A (PubMed:30194678). Phosphoethanolamine modification\nCC       of lipid A confers polymyxin resistance (By similarity). Confers\nCC       resistance to polymyxin-type antibiotics such as colistin\nCC       (PubMed:30194678). {ECO:0000250|UniProtKB:A0A0R6L508,\nCC       ECO:0000269|PubMed:30194678}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 38,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38",
  "source_sha256": "d75fc4c8bc738f05806f3af9945e4dc68a9d390599953db777a2ada2b9fa9923",
  "retrieved_utc": "2026-11-02T04:24:35.172422+00:00",
  "source_locator": "lines 108-108",
  "excerpt": "DR   GO; GO:0009244; P:lipopolysaccharide core region biosynthetic process; IEA:TreeGrafter.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 38,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1C3NEV1?format=txt&versions=38",
  "source_sha256": "d75fc4c8bc738f05806f3af9945e4dc68a9d390599953db777a2ada2b9fa9923",
  "retrieved_utc": "2026-11-02T04:24:35.172422+00:00",
  "source_locator": "lines 109-109",
  "excerpt": "DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 38,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 73784-73803",
  "excerpt": "[Term]\nid: GO:0007155\nname: cell adhesion\nnamespace: biological_process\nalt_id: GO:0098602\ndef: \"The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.\" [GOC:hb, GOC:pf]\nsubset: goslim_candida\nsubset: goslim_chembl\nsubset: goslim_drosophila\nsubset: goslim_euk_cellular_processes_ribbon\nsubset: goslim_generic\nsubset: goslim_metagenomics\nsubset: goslim_pir\nsubset: goslim_pombe\nsubset: goslim_prokaryote\nsynonym: \"cell adhesion molecule activity\" RELATED []\nsynonym: \"single organism cell adhesion\" RELATED []\nxref: Wikipedia:Cell_adhesion\nis_a: GO:0009987 ! cellular process\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0007155"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 94389-94401",
  "excerpt": "[Term]\nid: GO:0009244\nname: lipopolysaccharide core region biosynthetic process\nnamespace: biological_process\ndef: \"The chemical reactions and pathways resulting in the formation of the core region of bacterial lipopolysaccharides, which contains ten saccharide residues.\" [ISBN:0198506732]\nsynonym: \"lipopolysaccharide core region anabolism\" EXACT []\nsynonym: \"lipopolysaccharide core region biosynthesis\" EXACT []\nsynonym: \"lipopolysaccharide core region formation\" EXACT []\nsynonym: \"lipopolysaccharide core region synthesis\" EXACT []\nsynonym: \"LPS core region biosynthetic process\" EXACT []\nis_a: GO:0009312 ! oligosaccharide biosynthetic process\nrelationship: part_of GO:0009103 ! lipopolysaccharide biosynthetic process\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0009244"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 123641-123654",
  "excerpt": "[Term]\nid: GO:0016117\nname: carotenoid biosynthetic process\nnamespace: biological_process\ndef: \"The chemical reactions and pathways resulting in the formation of carotenoids, tetraterpenoid compounds in which two units of 4 isoprenoid residues joined head-to-tail are themselves joined tail-to-tail.\" [GOC:curators]\nsynonym: \"carotenoid anabolism\" EXACT []\nsynonym: \"carotenoid biosynthesis\" EXACT []\nsynonym: \"carotenoid formation\" EXACT []\nsynonym: \"carotenoid synthesis\" EXACT []\nxref: MetaCyc:CAROTENOID-PWY\nis_a: GO:0016109 ! tetraterpenoid biosynthetic process\nis_a: GO:0016116 ! carotenoid metabolic process\nis_a: GO:0046148 ! pigment biosynthetic process\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0016117"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 260149-260157",
  "excerpt": "[Term]\nid: GO:0044778\nname: meiotic DNA integrity checkpoint signaling\nnamespace: biological_process\ndef: \"A signal transduction process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA during meiosis. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and ends with signal transduction.\" [GOC:mtg_cell_cycle]\nsynonym: \"meiotic DNA integrity checkpoint\" EXACT []\nis_a: GO:0031570 ! DNA integrity checkpoint signaling\nis_a: GO:0033313 ! meiotic cell cycle checkpoint signaling\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0044778"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 129. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
